End-to-end approach for detecting and directing hypertrophic cardiomyopathy (HCM) patients.
Increasing awareness and reach for a potentially fatal, yet commonly missed disease
Potentially fatal, yet commonly missed disease
1 Million people in the US suffer from hypertrophic cardiomyopathy (HCM). Only 20% of those have been diagnosed, with 5 years to diagnosis.
HCM is a leading cause of sudden cardiac death in people under age 35, but if detected early and treated, patients can achieve high quality of life and normal longevity.
End-to-end approach for detecting and directing HCM patients
Viz HCM delivers real-time AI analysis of 12-lead ECGs to flag and triage suspected HCM cases to HCM specialists for diagnostic workup all from within the Viz HCM app.
Review patients identified by AI having suspected HCM
Direct patients to HCM specialists for additional workup
View echo images and reports to aid diagnosis of HCM
Viz HCM Algorithm Development and Performance
Robust Al Development
- 830k+ ECG exams from 300k individuals
- Covering non-obstructive and obstructive HCM
- Sourced from multiple locations globally
- Included racial & ethnic differences seen in PQRST-wave morphologies
Gold Standard Validated
- Cardiac MRIs